Is Levamisole registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Levamisole.

Is Levamisole approved by the US FDA?

Drugs@FDA lists 1 application product line for Levamisole, including ERGAMISOL (Discontinued).

Is Levamisole on the WHO Model List of Essential Medicines?

Yes — 6.1.1. Intestinal anthelminthics (core list): Ascariasis.

Active substance

Levamisole

SFDA 3
US FDA 1
WHO EML 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
KETRAX SYR 40MG-5ML	8 mg/ml	Syrup · Oral use	1 Bottle	SAR 5.80	NCE · Prescription	AstraZeneca	Withdrawn by MAH · Not Marketed
KETRAX TAB 40MG	40 mg	Tablet · Oral use	30 Blister	SAR 26.05	NCE · Prescription	AstraZeneca	Withdrawn by MAH · Not Marketed
KETRAX TAB 40MG	40 mg	Tablet · Oral use	3 Blister	SAR 3.30	NCE · Prescription	AstraZeneca	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
ERGAMISOL	EQ 50MG BASE	tablet · oral	JANSSEN PHARMA	Discontinued	18 Jun 1990

WHO WHO Model List of Essential Medicines (2025)

6.1.1. Intestinal anthelminthics · core
Ascariasis
Oral > Solid > tablet: 50 mg (as hydrochloride); 150 mg (as hydrochloride) (EML)

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.